In humans, SuFu mutations are associated with Gorlin’s syndrome, a hereditary condition characterised by increased risk of developing various forms of tumours, such as basal cell carcinoma and medulloblastoma (MB)10–12. Here, SUFU is linked to medulloblastoma.